XADAGO is a monoamine oxidase type B (MAO-B) inhibitor indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes XADAGO (safinamide) tablets for injection, for intravenous use. Xadago (safinamide) was approved as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes by: Food and Drug Administration (FDA), USA, March 21, 2017, European Medical Agency (EMA), European Union, February 24, 2017, herapeutic Goods Administration (TGA), Australia, November 2, 2018 and Health Canada (as Onstryv), January 9, 2019.

Where can I buy Xadago Tablets?

Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India. with over 20 years of domain experience.

The order for Xadago (safinamide) Tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

For Xadago or Safinamide Tablets price in India. Please call at M: +91 9811747774 or Email us at neeraj@indianpharmanetwork.co.in to know more details about the medicine and its cost price in India.
XADAGO (safinamide) tablets

Get In Touch

Facilitator under Patient Assistance Programs In India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Xadago (safinamide) on prescription and Import License in Patient's Name only.

For overseas patients, Xadago (safinamide) Tablets can be made available in Send your enquiry to find Xadago (safinamide) Tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

Dosage Forms and Strengths

Tablets: 50 mg and 100 mg.


FDA News Release

Newron Pharmaceuticals to Present at Jefferies 2018 Healthcare Conference
Dated: May 29, 2018